Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 5th International Conference on Neglected Tropical & Infectious Diseases Boston, MA, USA.

Day 2 :

Conference Series Neglected Tropical Diseases 2018 International Conference Keynote Speaker Eugenie Bergogne Berezin photo
Biography:

Deanna Mulvihill has her expertise in evaluation and passion for improving the health and wellbeing. Her open and contextual evaluation model based on responsive constructivists creates new pathways for improving healthcare. She has built this model after years of experience in research, evaluation, teaching, and administration both in hospital and education institutions. The foundation is based on fourth-generation evaluation (Guba & Lincoln, 1989) which is a methodology that utilizes the previous generations of evaluation: measurement, description and judgment. It allows for value-pluralism. This approach is responsive to all stakeholders and has a different way of focusing.

 

Abstract:

2014,17,01, an Editorial entitled “Planetary viral extension” underlined the insufficient attention of Occidental Countries to the 20 EBOLA epidemics within 30 years, with 9936 cases and 4877 deaths. Guinea, Liberia, Sierra Leone were the most contaminated populations. Starting in Guinea WHO announced 2000 deaths. A French investigation published in 2007 had described a blaze-off epidemics only in 1995 in Kinshasa West with 250 deaths. Since then a brutal development of the disease extremely contagious has gained a rapid geographical extension in all Sub-Saharan Africa, Zaire, Soudan as well as West African countries. A worldwide interest in the disease (the journal TIME in 2014 “now arriving the deadly Ebola virus lands in America” (death was waiting for the traveler). Four major analyzes: (a) Epidemiology: including local surveillance, containment measures, WHO and journals of instant information. (b) Measures Since 2007: CDC-Mobile laboratories, surveillance of suspects or alerts or probable  (febrile or hemorrhagic or deaths cases) (immediately notified). (c) The office of “rumors” (news) (WHO: gloves, javel, mosquitos). Ebola is transmitted directly by contact, imposing the “salut EBOLA” (EBOLA fistful). (d) Funerals major source of contamination with traditional cleaning, embalms in close contact with the body and family members. Containment, surveillance, education, hygiene, medical personnel are current. WHO “Staff at the  outbreak sites see evidence that the nimbers of reported cases and deaths underestimate the magnitude of the outbreak.”

 

Keynote Forum

Stef Stienstra

Royal Dutch Navy, The Netherlands

Keynote: Drug delivery by tattooing to treat cutaneous leishmaniasis
Conference Series Neglected Tropical Diseases 2018 International Conference Keynote Speaker Stef Stienstra photo
Biography:

Dr. Stef Stienstra works internationally for several medical and biotech companies as the scientific advisory board member and is also an active reserve-officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces, he is CBRN specialist with the focus on (micro)biological and chemical threats and medical- and environmental functional specialist within the 1st CMI (Civil-Military Interaction) Battalion of the Dutch Armed Forces. For Expertise France he is now managing an EU CBRN CoE public health project in West Africa. He is visiting professor for the University of Rome Tor Vergata in Italy for the CBRN Masters Course and lecturer for the NATO School in Oberammergau in Germany and the Joint NATO CBRN-Defense Center of Excellence in Vyskov in the Czech Republic. In his civilian position, he is at this moment developing with MT-Derm in Berlin (Germany) a novel intradermal vaccination technology as well as a new therapy for cutaneous leishmaniasis for which he has won a Canadian ‘Grand Challenge’ grant. With Hemanua in Dublin (Ireland) he has developed an innovative blood separation unit, which is also suitable to produce convalescent plasma for Ebola Virus Disease therapy. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a doctorate and has extensive practical experience in cell biology, immuno-hematology, infectious diseases, biodefense, and transfusion medicine. His natural business acumen and negotiation competence help to initiate new successful businesses, often generated by unexpected combinations of technologies.

 

Abstract:

Leishmaniasis is a vector-borne disease that is caused by obligate intra-macrophage protozoa of the Leishmania species. Leishmaniasis can cause different clinical syndromes, including cutaneous leishmaniasis (CL), in which the patient generally presents with one or several ulcers (s) or nodule(s) on the skin, resulting from the infection of phagocytic cells located in the dermis. It often results in severe scar tissue in the skin. Most of the twelve million people infected with Leishmania worldwide are CL cases, a 1.5 million new cases occur annually.

 

Keynote Forum

Ivana Haluskova Balter

French society of immunology, France

Keynote: Tackling neglected diseases in current context
Conference Series Neglected Tropical Diseases 2018 International Conference Keynote Speaker Ivana Haluskova Balter photo
Biography:

Haluskova Balter Ivana , MD,MBA, France, French/Slovak active medical professional specialised in infectious diseases, internal medicine covering various therapeutic axes, certified in Immunology and Pediatric, MBA in vaccinology. Lived multi-country medical “field “experience  in Southeast Asia, West/Central/East Europe and Middle East. Speaking French, English, Russian, Italian, Czech, and Slovak with notion of Mandarin. Over 15   years of experience in pharmaceutical research and development for European and USA companies as Medical lead /Director of R&D in various therapeutic areas and as Scientific and Medical independent consultant for various academic and private stakeholders globally. Active member of French immunology society (SFI) administrative board and several international academic societies with focus on R&D  innovation and partnership highlighting role immunology/immune-metabolism and genetics for innovative treatment, prevention and diagnostic. Member of advisory Health concern (India) and think tank group in order to attract attention to role of accessible medical care, education and awareness along with accurate diagnostic and innovative partnership in this area. Years of expertise to work globally but recently more focused on BRICS as  Medical advisor for scientific partnership, bringing new innovative concepts alive and getting them endorsed.

 

Abstract:

The fight against the Neglected Tropical Diseases receiving increased  worldwide attention after the recent attribution of the 2015 Nobel Prize in Physiology or Medicine to William Campbell and Satoshi ÅŒmura for their development of a novel therapy against infections caused by roundworm parasites. Neglected tropical diseases (NTDs) known to be a diverse and growing group of communicable diseases that prevail in tropical and subtropical conditions in 149 countries affect more than one billion people and cost developing economies billions of dollars every year. Populations living in poverty, without adequate sanitation and in close contact with infectious vectors and domestic animals and livestock are those worst affected. Despite encouraging progress, millions of people still need free high-quality treatments and millions more still need care and treatment for human dog-mediated rabies, echinococcosis, leishmaniasis and other neglected tropical diseases seemingly difficult to treat. Neglected tropical diseases program in global manner encompass biology of parasites and their vectors. Its research program addresses global public health concerns in terms of disease prevention, control and antiparasitic treatment. Along with understanding of the dynamic interactions between these microorganisms and their hosts, identifying the fundamental bases of parasitism and transmission by vectors, host invasion mechanisms, and determine parasite factors underlying virulence and pathology of these organisms. From scientific point of view, tackling infectious and tropical disease encompass various aspects including like transmission mechanisms, virulence factors, pathogens reservoirs, host immune response working transversally through epidemiology , microbiology, genetics and genomics, cell biology, biochemistry and bioinformatics and imaging. Apart vector born diseases like Dengue and Zika recent research in France look particularly on three key eukaryotic pathogens responsible for severe parasitic diseases that have a significant health and economic impact and affect most of the world’s population: Plasmodium the causative agent of malaria, Leishmania – the agent of leishmaniasis, and Trypanosoma brucei – responsible for sleeping sickness. The Anopheles mosquito, which is the vector of Plasmodium and a number of arboviruses, is being studied along with the tsetse fly, the vector of African trypanosomiasis. Fundamental research on  in vitro and in vivo models – including field work in Africa, Asia, South America – with applied research on resistance to antimalarial drugs and on the discovery of new antiparasitic drugs include exploration of traditional medicine and methods like reverse pharmacology.Accurate diagnostic and surveillance with better understanding of genetic and immunologic background of host specific response and pathogen evolution drives adapted vaccine research but also preventive interventions. As one of examples to illustrate it, global mapping of resistance to artemisinin (the KARMA study driven by Institut Pasteur in Paris and the Institut Pasteur in Cambodia and members of Institut Pasteur International Network) monitoring risk of spread of artemisine resistance from Asia to Africa using discovery of kelch(K13)–propeller domains as the primary determinant of artemisinin resistance. Immunology is relatively new science about composition, functions, reaction of immune system. Host immune system co-evolute with pathogens and commensal microbiota given individual genetic predispositions and variability and remains along with neuroendocrine system one of the key to maintain homeostasis of organism. Knowledge in immunology is growing and providing clinically valuable solutions across various for diagnostic, preventive (innovative vaccination ) and treatment strategies including neglected and tropical diseases. Based on works natural defences to infection are mediated by intrinsic/innate and adaptive immune responses. Understanding the role of early metabolic mediators of inflammatory responses to infection and principles of immuno-metabolism expect to help in the development of urgently needed host directed therapeutic, preventive (vaccines) and diagnostic  innovations knowing limitations of existing tools.

 

  • Infectious Diseases | Pathogenesis and Immunity | Drug Discovery for NTDs & Infectious Diseases | NTD’s Vaccines: Challenges and Approaches | Translational Strategies to Prevent NTD’s & Infectious Diseases | NTD’s & Infectious Diseases Eradication: Novel Technologies and Treatments | Advances in Vector Biology Research
Location: Crowne Plaza Boston-Newton 320 Washington Street, Newton, MA 02458, USA
Speaker

Chair

Ivana Haluskova Balter

French society of immunology, France

Biography:

Abstract:

Malaria is a disease of global concern. The resistance of Plasmodium falciparum to drugs such as chloroquine and sulfadoxine-pyrimethamine is a major problem in malaria control. Artemisinin derivatives, particularly in combination with other drugs, are thus increasingly used to treat malaria, reducing the probability that parasites resistant to the components will emerge. Artemisinin resistance has recently been reported in the Thai-Cambodia border. The project was designed to demonstrate resistance-mitigating effects of phytochemical A. annua of Artemisia annua relative to pure artemisinin against the rodent malaria parasite Plasmodium berghei ANKA and Plasmodium yoelii. The in vivo experiments were done by inoculating the Swiss albino mice with the P. berghei ANKA parasite and P. yoelii and thereafter treated them with pure artemisinin and Artemisia annua phytochemicals. After 4 days parasitemia was determined and the ED50 and the ED9O  calculated and then the mice were passaged. The ED values got were utilized to determine the doses to be used for resistance development. The ED50 and ED90 got for artemisinin with P. berghei ANKA was 1.43 and 7.18 mg/kg.day respectively, while the ED50 and ED90 got for the A. annua with P. berghei ANKA was 34.5 and 118 mg/kg.day respectively. The chloroquine-resistant murine Plasmodium (P. yoelii) values were as follows artemisinin ED50 and ED90 got was 11.63 and 29.8 mg/kg.day respectively. The efficacy of dihydroartemisinin was also determined in order to compare with artemisinin and the ED50 and ED90 got for DHA with P. berghei ANKA was 1.73 and 8.31 mg/kg.day respectively. In order to determine resistance development, the ED50 and ED90 were determined after every 10 cycles. This was compared with the values that had been obtained before exposure to the drug pressure. The relative index was calculated as final ED50 divided by the parental ED50. The results indicated that there was an incremental increase in the Relative index with an increase in cycles in both P. yoelii and P. berghei ANKA. Resistance obtained in the two murine plasmodium parasites was found to be transient.

 

Speaker
Biography:

Ayat Zawawi is a PhD student at the University of Manchester. She is a Lecturer at King Abdul-Aziz University in Jeddah, KSA, Faculty of Applied Medical Sciences.           
 

 

Abstract:

Trichuris trichiura (whipworm) is a soil-transmitted helminth parasite that affects around 500 million people worldwide, resulting in disability and poor child development, especially in areas of poor hygiene and sanitation. The ideal vaccine to protect against T. trichiura in humans would include protein epitopes that elicit a protective T helper cell type 2 immune response. Herein, we used bioinformatics tools to identify candidate histocompatibility complex class II (MHC-II) molecule T cell epitopes from known Trichuris muris proteins selected using inclusion and exclusion criteria. T. muris is the murine whipworm that is closely related to the human pathogen making it a relevant model parasite. A number of prediction tools are available for the identification of peptides that bind to MHC II molecules. The lack of standardized methodology and the difficulty of MHC II epitope prediction make the selection of an appropriate prediction tool difficult. This study reports a systematic review to choose the most appropriate tools to predict MHC II epitopes. Subsequently, up to fifteen epitopes were predicted, from the selected T. muris proteins and expressed on Hepatitis B core antigen virus-like particles (HBc-Ag). HBc+ T cell epitopes were tested in vitro to address whether they activate antigen presenting cells. We also immunized normally susceptible mice with the HBc+ T cell epitopes prior to infection with T. muris to test the protective immune response in vivo. The predicted epitopes identified using the right combination of immunoinformatics and immunogenicity screening tools have the potential to bring T. trichiura to vaccine trial.  

 

Biography:

Simon Raymond is a Consultant who specialized in Medical and Scientific Research and an Alumnus of Melbourne University (Rank of Number 1 in Australia and Number 33 in the World). The above stated Researcher has acted as a Reviewer for the respected Medical Journal of Australia, has received invitations internationally to review from prestigious medical journals including the Journal of American Medical Association Network. He has received the award in recognition of his research by Royal Australasian College of Surgeons (PSC, 2006) and invited to conferences internationally as an official Delegate and Researcher, including that in USA and China. He has worked as the Principal Researcher in the highest-powered form of medical trial-Randomized Controlled Trial (RCT). The above stated Researcher is also a Member of the Golden Key International Society for Honored and outstanding Academics and has been cited as a Notable Global Leader.

 

Abstract:

The current researcher has in previous conferences and publications detailed the conceptualization and development of the new, or third, branch of antimicrobial therapeutics, namely site attachment inhibition which involves negation of cellular attachment by infective agents. This based on the issues with metaphorical superbugs, development of antimicrobial resistance, and the general lack of success currently with respect to the previous two branches which focused on (1) replication of infective agent and, (2) immune system enhancement. This talk explains that site attachment inhibition is intended to consist of both treatment of established infection but also new generation immunization programs. The likely success of new generation immunization programs, based on prenatal stem cell therapy is intended to involve gene mutagenesis or knockout. This preventative (or, immunization) therapy intended to be spanning right back to spermatogenesis and oogenesis. The validation for likely success includes the innate resistance or immunity achieved by inherited genetic mutations, including CCR5-Δ32 against HIV. One major issue is a differentiation between association and causation. Even the known CCR5-Δ32 mutation has not been completely confirmed as direct/causative of the inhibition of attachment observed in research analyses. New content presented in this talk will involve methods around the above issues to do with association and causation. These methods include the use of CRISPR technology in order to analyze properly the genes (and, methods) utilized by those with innate resistance (immunity) in order to determine the proper prenatal genetic therapy, as mentioned above, in new generation immunization programs. Prenatal genetic therapy is becoming increasingly discussed and utilized in medicine and surgery. However, an important issue remains the ethics committee and community consideration in such treatment strategy consideration.

 

Hanaa A Siam

Federal Ministry of Health, National Public Health Laboratory, Sudan

Title: Effectiveness of Community-based Dengue Vector Control: Trial in Kassala City- Eastern Sudan
Speaker
Biography:

Hanaa Adli Siam, a scientific researcher in Department of Medical Entomology – National Public Health Laboratory –Federal Ministry of Health – Sudan, since 2012. She has a Master degree in Medical Entomology and vector control from Faculty of Science - University of Khartoum 2010. She has two published papers and participated in about ten international conferences and workshops

Abstract:

Dengue is becoming an endemic disease in Eastern Sudan with repeated outbreaks during last two decades. This study aimed to investigate an effective method for community participation in dengue vector control (Aedesaegypti) in Kassala city. The study was conducted during May to December 2011. A cluster was composed in eight neighborhood; each cluster was formed of three grouped houses.  One of these grouped houses was allocated randomly into one of three study arms: arm1 intervention of community volunteers; arm 2: intervention of house holder education and arm 3: Control. In arm 1, sixteen volunteers (two per cluster) inspected the water containers of houses weekly. In the house hold arm 2, householders received two educational sessions for breeding site of vectors source elimination and management of their water containers. In the control arm, houses did not receive any interventions. Bimonthly Entomological survey was conducted for eight months in each cluster of the study. The covering situation of inspected water containers was also recorded. From 9537 inspected containers, 545(5.71%) containers were found positive for aquatic stages of Aedes. aegypti. Zieers (localwater containers) composed 436 (80%) from the positive containers. ANOVA analyses were done between the three arms and no significant differences were found. Those entomological indices declined in community volunteers and householders arms. Also, the percentage of covering Zieers increased from 14.1% to 64.7% in community volunteer’s arm and from 12.1% to 32.6% in house holder arm. In control arm there was a fluctuation in all parameters. The arm of Community volunteers may be more effective in increasing the awareness of covering containers and decline of the entomological indices. Thus, it may be used as an approach for community participation in Dengue vector control in Kassala city.

 

Speaker
Biography:

Sana Ullah is an active veterinarian who has got his DVM degree from Sindh Agriculture University Tandojam, Pakistan. He has a very good experience in parasitological lab techniques, sedimentation method, flotation method and direct smear method for identification of eggs for various parasites. He has done research work on comparative studies on dressing percentage and distribution of cut parts in broiler and layer, in collaboration with the department of Animal Products and Technology. He has also performed a research project on, prospective evaluation of pain in dogs undergoing ovariohysterectomy and castration in dogs from the department of surgery and obstetrics.

 

Abstract:

Six female dogs were operated for ovariohysterectomy and six male dogs were castrated to assess the severity of pain, wound healing and its complications if any from post-operative care. The heart rate, body temperature, and respiratory rate were also recorded. Body temperature, heart rate and respiration in male and female dogs during the process of operation differed significantly (P<0.05). On average the body temperature of female dogs was significantly higher (102.01±0.91°F) than the male dogs (1 OI .86±0.60°F). The heart rate of female dogs was significantly higher (109.42±23.06 beats/minute) than the male dogs (95.42±15.97 beats/minute). Respiratory rate of female dogs was significantly higher (40.68±5.07 breath/minute) than the male dogs (35.93±6.03 breaths/1 minute). The post-operative body temperature on average of female dogs (ovariohysterectomy) was higher than the male dogs castrated. The heart rate varied between animals of the same sex and on the average heart rate of female dogs was higher than the male dogs. The respiration also varied between animals as well as between male and females, but respiration rate was higher in female dogs than the male dogs. The female and male dogs varied markedly in relation to postoperative pain due to their respective operations. There was great variation between dogs for the degree of pain or severity of pain after ovariohysterectomy surgery and is might be associated with the physical health of these animals. The male dogs physically were of different health conditions and may be the weaker dogs felt prolonged pain as compared to those with good health.

 

Speaker
Biography:

Dr Benjamin Koudou has over 16 years’ experience as a researcher malaria and filariasis control specialist and, a laboratory scientist and researcher working in the fields of neglected tropical disease (NTD) control in Africa, particularly focusing on elimination of preventive chemotherapy diseases (lymphatic filariasis, onchocerciasis, Schistosomiasis, STH) through mass drug administration. From April 2012 to August 2016, Benjamin support lymphatic filariasis elimination programmes in West African countries. Benjamin is also highly experienced in capacity development and in establishing quality management system for laboratories. Currently, Dr Koudou was primary and secondary supervisor of 7 PhD students who defended successfully from 2012 to 2017 at University of Liverpool and Basel University in Switzerland. Additionally, Benjamin was invited as several international conferences as invited key note speakers and published close to 60 papers in peer reviewed international journals. Dr Koudou was Principal Investigator of several research projects focused on including randomized controlled trials targeting lymphatic filariasis.

 

Abstract:

Lymphatic filariasis (LF) is a major cause of acute and chronic morbidity and a significant impediment to socioeconomic development in 73 middle and low-income countries. The disease affects 120 million people and a further 1.4 billion are also at risk of acquiring the disease through exposure to mosquito bites. The Global Programme to Eliminate Lymphatic Filariasis (GPELF) through the WHO strategy of preventive chemotherapy and transmission control (PCT), has targeted LF for elimination by 2020. This will be achieved mainly by the mass drug  (MDA) of albendazole in combination with either ivermectin or diethylcarbamazine citrate (DEC). GPELF is one of the most rapidly expanding global health programs administering more than 540 million treatments in 54 countries in 2012. The MDA campaign has been most effective in the middle-income economies of Southeast Asia where all 15 endemic countries have initiated MDA. In Africa, only 18 of the 34 endemic countries were implementing MDA in 2012.  Many of the communities in countries yet to start MDA for LF elimination are in hard to reach areas in post-conflict environments with poor health systems infrastructure. Nevertheless, PCT presents an excellent platform for integrated control of other neglected tropical diseases (NTDs) where several diseases coexist, given that either or both ivermectin and albendazole are effective against onchocerciasis and soil-transmitted helminthiasis. However, there are other challenges to be addressed if the 2020 target is to be achieved. The scientific community will need to address the issue of NTD elimination in urban settings (mainly LF and STH) and the persistence of LF transmission in countries where MDA started for many years.

 

Speaker
Biography:

Mr. Orok akwaowo bassey is a research staff of the Nigerian Institute of Medical Research, Lagos, Nigeria. A holder of M.SC in Medical Parasitology, he is currently studying for a PhD degree in the College of Medicine, University of Lagos, Nigeria. He has published 10 papers in reputed journals.

 

Abstract:

In malaria diagnosis and management, parasite-based detection by microscopy remains the cornerstone of diagnosis. However, lack of expertise in staining, slide reading and inability to detect sequestered parasites in deep capillaries are the common demerits of microscopy.  Recently, the easy to use RDTs in the diagnosis of malaria have been adopted to overcome microscopy challenges. RDTs are now being used in homes and in Primary health care centers and the call to ensure precision and quality of services cannot be overemphasized. This study was carried out to determine the sensitivity and specificity of HRP2. A total of 142 (6-15 years) participants were tested.  Inclusion criteria were participants with axillary body temperature, not ˃ 37.50C, Hemoglobin level not Ë‚ 13.0g/dl and White blood cells, not Ë‚4000/cm3.  Two screening methods were used: Pf-HRP2 antigen and microscopy.  Out of the 142 sample tested, 10 (21.1%) tested positive by HRP2 and, 12 (28.3%) by microscopy with sensitivity and specificity at 95% CI being 95.8% and 99.5% respectively (P=0.001). In conclusion, both methods show a diagnostic agreement in precision and reliability in the detection of asymptomatic falciparum malaria.  

 

Ernest Tambo

1Africa Disease Intelligence and Surveillance, Communication and Response (Africa DISCoR) Institute, Cameroon

Title: The price of evidence-decision policy-tailored NTDs insurance in NTDs risk surveillance and epidemic public health burden management actions in sub-Saharan Africa
Biography:

Abstract:

There is dearth of on evidence policy translation and actions on NTDs risk surveillance and emerging epidemic public health emergency management that pose significant economic concern. Yet the positive value robust and sustainable NTDs surveillance and response systems coupled with advantages of mobile health and digital applications in improving care service deliver quality and access, promoting patient-provider dialogue and mutual learning data and information  sharing remain untapped in the continent. While, the persistence of NTDs and other emerging invasive infectious diseases of poverty public health needs and economic burden continues to ravage high risk and vulnerable populations in sub-Saharan Africa. The price of assessing NTDs risk management and epidemic public health outweighs and underscores the risk of neglect and immense price of assessing NTDs risk management and epidemic public health benefits. The paper analyses practical and effective policy-tailored NTDs insurance approaches and strategies implications and challenges to provide coverage for specific expenses, geographies, types of disease and times. Furthermore, in delivering evidence-based decisions-making policy, actions plans on NTDs threat and epidemics prevention, emergency response and control/containment interventions benefits of such protection and ensuring that exposures are appropriately NTDs, early detection, delivery prevention and management care services in urban remote settings against potential losses in sub-Saharan Africa and worldwide.

 

Speaker
Biography:

Mr. Orok, akwaowo Bassey is a research staff of the Nigerian Institute of Medical Research, Lagos, Nigeria. A holder of M.SC in Medical Parasitology, he is currently studying for a Ph.D. degree in the College of Medicine, University of Lagos, Nigeria. He has a research interest in apicomplexan parasites, Immunology, and non-communicable diseases. He has published 10 papers in reputed journals.

 

Abstract:

Toxoplasmosis is the most common zoonotic infection of humans with immense public health importance.  Infection gravitates especially in a habitational setting where poverty, ignorance and low level of hygiene holds sway.  This cross-sectional study investigates the seroprevalence of toxoplasmosis and co-infection with falciparum malaria among nomads. Eighty-four (84) apparently healthy individuals randomly selected, comprising 53 (63.1%) male and 31 (36.9%) females in Sabo, a nomadic settlement in Ikorodu, Lagos State, Nigeria were enrolled for the study. Questionnaires were administered to capture socio-demographic data. Enzyme-linked immunosorbent assay (ELISA) was used to determine the presence of Toxo-IgG/IgM antibodies in blood samples collected for previous and current infections.  Malaria determination was done using SD- Bioline P. falciparum-histidine rich protein2 (pf-HRP2) antigen test kit and microscopy. Data were analyzed using SPSS version 20.  From our result, the seroprevalence of anti-Toxoplasma IgG and IgM antibodies was found to be 28 (33.3%) and 84(100%) respectively (P=0.006, P>0.05). Although all the enrollees had previous exposure to toxoplasmosis, new infection was common in males 17(60.71%) and female 11(39.29%). A total of 8 (9.5%) enrollees had asymptomatic falciparum malaria and cases of toxoplasmosis-malaria co-infection were found to be 3 (37.5%). Findings from this study indicate the high level of Toxoplasma gondii infection exposure in a nomadic settlement with recommendations for public education.

 

Speaker
Biography:

Gustave Simo completed his Ph.D. in Molecular Parasitology in 2001 from the University of Yaoundé 1 (Cameroon) and his Habilitation from the University of Montpellier (France). He was Visiting Scientist at Bay Paul Center of MBL at Woods Hole. His postdoctoral studies were performed at the Division of Functional Genome analysis of the German Cancer Research Center of Heidelberg and at the “Institut de Recherche pour le Développement” of Montpellier. He published more than 50 papers in reputed journals where he has been serving as referee. He is heading the Molecular Parasitology and Entomology Unit of the University of Dschang, Cameroon.

 

Abstract:

Soil-transmitted helminthiases (STH) belong to neglected tropical diseases affecting billion of people. Preventive chemotherapy reduced STHs incidence and led to their inclusion into WHO roadmap for elimination. In such a context where large-scale epidemiological studies are required to validate and monitor the elimination, no reliable diagnostic test is available. Efforts on molecular diagnostic of STHs were limited by the use of commercial kits which do not favor large-scale studies. In this light, four DNA extraction methods were tested on stools infected by Ascaris lumbricoides and their performance was evaluated by amplifying A. lumbricoides DNA. Stools were analyzed in triplicate by Kato-Katz and flotation techniques. Aliquots of 10, 20, 40 and 80 milligrams of infected stools were made and Zymo Quick-DNA kit, chelex, thaw-boiled and CTAB extraction methods enabled to extract DNA from these aliquots. Specific primers were used to amplify A. lumbricoides DNA. Of the 316 stools collected, the flotation technique revealed ten (3.2%) with A. lumbricoides. No infection was identified by Kato-Katz. Of the 10 infected stools, no amplification was observed for extracts coming from chelex and thaw-boiling methods. All extracts from the CTAB method and zymo Quick-DNA kit revealed A. lumbricoides whatever the amount of stool tested. In remote clinical laboratories, the flotation technique is appropriate for the identification of STHs in the current elimination context. The CTAB based method is appropriate to extract DNA from stools. It requires the little amount of stool and its low cost could favor large-scale epidemiological studies.